| Citation: |
WU Chunyan, SONG Xiaodi, MA Xun, ZHANG Xiaoqian. Pituitary Metastasis of Breast Cancer: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2025, 52(4): 342-346. DOI: 10.3971/j.issn.1000-8578.2025.24.0985
|
Competing interests: The authors declare that they have no competing interests.
| [1] |
Javanbakht A, D'Apuzzo M, Badie B, et al. Pituitary metastasis: a rare condition[J]. Endocr Connect, 2018, 7(10): 1049-1057. doi: 10.1530/EC-18-0338
|
| [2] |
蔡恒, 刘文静, 冯天达, 等. 垂体转移瘤的临床特点及治疗分析: 2例病例报道及文献回顾[J]. 中国医科大学学报, 2019, 48(6): 564-567. [Cai H, Liu WJ, Feng TD, et al. Clinical characteristics and treatment of pituitary metastases: two case reports and literature review[J]. Zhongguo Yi Ke Da Xue Xue Bao, 2019, 48(6): 564-567.]
Cai H, Liu WJ, Feng TD, et al. Clinical characteristics and treatment of pituitary metastases: two case reports and literature review[J]. Zhongguo Yi Ke Da Xue Xue Bao, 2019, 48(6): 564-567.
|
| [3] |
Dedeker C, Archibald H, Meares A, et al. Metastatic breast cancer masquerading as a pituitary macroadenoma: A case report[J]. SAGE Open Med Case Rep, 2022, 10: 2050313X211073243.
|
| [4] |
杨嘉欣, 叶建红, 田晓娜, 等. 以尿崩症为首发表现的肺腺癌垂体转移1例[J]. 中国实验诊断学, 2022, 26(9): 1397-1399. [Yang JX, Ye JH, Tian XN, et al. Pituitary metastasis of lung adenocarcinoma presented with diabetes insipidus as the first manifestation: a case report[J]. Zhongguo Shi Yan Zhen Duan Xue, 2022, 26(9): 1397-1399.] doi: 10.3969/j.issn.1007-4287.2022.09.034
Yang JX, Ye JH, Tian XN, et al. Pituitary metastasis of lung adenocarcinoma presented with diabetes insipidus as the first manifestation: a case report[J]. Zhongguo Shi Yan Zhen Duan Xue, 2022, 26(9): 1397-1399. doi: 10.3969/j.issn.1007-4287.2022.09.034
|
| [5] |
Al-Aridi R, El Sibai K, Fu P, et al. Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review[J]. Pituitary, 2014, 17(6): 575-587. doi: 10.1007/s11102-013-0542-9
|
| [6] |
朱锡群, 刘细国. 以尿崩和视力下降为主要表现的垂体转移瘤[J]. 国际神经病学神经外科学杂志, 2020, 47(4): 412-413. [Zhu XQ, Liu XG. Pituitary metastatic tumor with the manifestations of diabetes insipidus and visual field deficits[J]. Guo Ji Shen Jing Bing Xue Shen Jing Wai Ke Xue Za Zhi, 2020, 47(4): 412-413.]
Zhu XQ, Liu XG. Pituitary metastatic tumor with the manifestations of diabetes insipidus and visual field deficits[J]. Guo Ji Shen Jing Bing Xue Shen Jing Wai Ke Xue Za Zhi, 2020, 47(4): 412-413.
|
| [7] |
傅成斌, 韩晖, 林舜国, 等. 吡咯替尼联合曲妥珠单抗和帕妥珠单抗新辅助治疗HER-2阳性乳腺癌的回顾性研究[J]. 中国肿瘤临床, 2023, 50(17): 882-887. [Fu CB, Han H, Lin SG, et al. A retrospective study of pyrrotinib combined with trastuzumab and pertuzumab neoadjuvant therapy for HER-2 positive breast cancer[J]. Zhongguo Zhong Liu Lin Chang, 2023, 50(17): 882-887.] doi: 10.12354/j.issn.1000-8179.2023.20230648
Fu CB, Han H, Lin SG, et al. A retrospective study of pyrrotinib combined with trastuzumab and pertuzumab neoadjuvant therapy for HER-2 positive breast cancer[J]. Zhongguo Zhong Liu Lin Chang, 2023, 50(17): 882-887. doi: 10.12354/j.issn.1000-8179.2023.20230648
|
| [8] |
曲珍, 王轩, 徐圣秋. 安罗替尼致新的不良反应2例分析[J]. 海峡药学, 2021, 33(10): 179-181. [Qu Z, Wang X, Xu SQ. Analysis of two new adverse reactions induced by amrotinib[J]. Hai Xia Yao Xue, 2021, 33(10): 179-181.] doi: 10.3969/j.issn.1006-3765.2021.10.070
Qu Z, Wang X, Xu SQ. Analysis of two new adverse reactions induced by amrotinib[J]. Hai Xia Yao Xue, 2021, 33(10): 179-181. doi: 10.3969/j.issn.1006-3765.2021.10.070
|
| [9] |
Tomkins M, Lawless S, Martin-Grace J, et al. Diagnosis and Management of Central Diabetes Insipidus in Adults[J]. J Clin Endocrinol Metab, 2022, 107(10): 2701-2715. doi: 10.1210/clinem/dgac381
|
| [10] |
Priya G, Kalra S, Dasgupta A, et al. Diabetes Insipidus: A Pragmatic Approach to Management[J]. Cureus, 2021, 13(1): e12498.
|
| [11] |
黄林丽, 朱丰林, 刘春红, 等. 白塞病合并中枢性尿崩症1例并文献复习[J]. 中国现代医生, 2023, 61(12): 140-142. [Hang LL, Zhu FL, Liu CH, et al. Behcet's disease with central diabetes insipidus: a case report and literature review[J]. Zhongguo Xian Dai Yi Sheng, 2023, 61(12): 140-142.]
Hang LL, Zhu FL, Liu CH, et al. Behcet's disease with central diabetes insipidus: a case report and literature review[J]. Zhongguo Xian Dai Yi Sheng, 2023, 61(12): 140-142.
|
| [12] |
Komninos J, Vlassopoulou V, Protopapa D, et al. Tumors Metastatic to the Pituitary Gland: Case Report and Literature Review[J]. J Clin Endocrinol Metab, 2004, 89(2): 574-580. doi: 10.1210/jc.2003-030395
|
| [13] |
许卓华, 陆颖, 杨慧, 等. 罕见乳腺癌垂体转移瘤病例报道并文献分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(20): 183-184. [Xu ZH, Lu Y, Yang H, et al. Rare pituitary metastasis of breast cancer: case report and literature review[J]. Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai(Lian Xu Xing Dian Zi Qi Kan), 2020, 20(20): 183-184.]
Xu ZH, Lu Y, Yang H, et al. Rare pituitary metastasis of breast cancer: case report and literature review[J]. Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai(Lian Xu Xing Dian Zi Qi Kan), 2020, 20(20): 183-184.
|
| [14] |
Jourdan A, Zaidi SMA, Iftikhar H, et al. Pituitary metastasis from a high grade serous ovarian carcinoma presenting as hyponatremia with masked diabetes insipidus: A case report[J]. Surg Case Rep Adv Tech, 2024, 2: 100023.
|
| [15] |
Wu CC, Ekanem TI, Phan NN, et al. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients[J]. Int J Med Sci, 2020, 17(18): 3112-3124. doi: 10.7150/ijms.49652
|
| [16] |
He W, Chen F, Dalm B, et al. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis[J]. Pituitary, 2015, 18(1): 159-168. doi: 10.1007/s11102-014-0552-2
|
| [17] |
Parthasarathy S, Lee DH, Levitt AH, et al. Pituitary Metastasis Presenting With Central Diabetes Insipidus and Panhypopituitarism[J]. AACE Clin Case Rep, 2022, 8(1): 15-18. doi: 10.1016/j.aace.2021.06.006
|
| [18] |
郭丰, 王莎莎, 秦贵军, 等. 以中枢性尿崩症为首发症状的垂体转移癌的临诊应对[J]. 中华内分泌代谢杂志, 2022, 38(4): 330-334. [Guo F, Wang SS, Qin GJ, et al. Approach to the patient with pituitary metastases initially manifested as central diabetes insipidus[J]. Zhonghua Nei Fen Mi Dai Xie Za Zhi, 2022, 38(4): 330-334.] doi: 10.3760/cma.j.cn311282-20210822-00536
Guo F, Wang SS, Qin GJ, et al. Approach to the patient with pituitary metastases initially manifested as central diabetes insipidus[J]. Zhonghua Nei Fen Mi Dai Xie Za Zhi, 2022, 38(4): 330-334. doi: 10.3760/cma.j.cn311282-20210822-00536
|
| [19] |
Castle-Kirszbaum M, Goldschlager T, Ho B, et al. Twelve cases of pituitary metastasis: a case series and review of the literature[J]. Pituitary, 2018, 21(5): 463-473. doi: 10.1007/s11102-018-0899-x
|
| [20] |
Meng M, Lin Y. Pituitary metastasis in HER-2 positive breast cancer with initial presentation of hypernatremia: Two case reports[J]. Curr Probl Cancer Case Rep, 2021, 4: 100107. doi: 10.1016/j.cpccr.2021.100107
|
| [21] |
Wu Q, Li J, Zhu S, et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study[J]. Oncotarget, 2017, 8(17): 27990-27996. doi: 10.18632/oncotarget.15856
|
| [22] |
Xiao W, Zheng S, Liu P, et al. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study[J]. Cancer Med, 2018, 7(3): 922-930. doi: 10.1002/cam4.1370
|
Figures(3)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: